Anxiety may amplify cognitive impairment in patients with elevated amyloid beta: Study

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2021-12-30 03:30 GMT | Update On 2021-12-30 03:30 GMT

A recent study published in the Alzheimer's Association supports a synergistic interaction between anxiety and Aβ in increasing the risk of cognitive decline.

Amyloid beta (Aβ) deposition may precede clinical symptoms of Alzheimer's disease (AD) by about 15 to 20 years. The field of AD and brain ageing has made substantial advances in biomarker measurements such that in living persons, cortical Aβ deposition can be visualized by amyloid brain imaging using various types of tracers.

A group of researchers investigated the longitudinal relationship between cortical amyloid deposition, anxiety, and depression and the risk of incident mild cognitive impairment (MCI).

The researchers followed 1440 community-dwelling, cognitively unimpaired individuals aged ≥ 50 years for a median of 5.5 years. Clinical anxiety and depression were assessed using Beck Anxiety and Depression Inventories (BAI, BDI-II). Cortical amyloid-beta (Aβ) was measured by Pittsburgh compound B positron emission tomography (PiB-PET) and elevated deposition (PiB+) was defined as standardized uptake value ratio ≥ 1.48. We calculated Cox proportional hazards models with age as the time scale, adjusted for sex, education, and medical comorbidity.

Cortical Aβ deposition (PiB+) independent of anxiety (BAI ≥ 10) or depression (BDI-II ≥ 13) increased the risk of MCI. There was a significant additive interaction between PiB+ and anxiety (joint effect hazard ratio 6.77; 95% confidence interval 3.58–12.79; P = .031) that is, being PiB+ and having anxiety further amplified the risk of MCI.

Thus, the researchers concluded that the current study mostly supports a synergistic interaction between anxiety and Aβ in increasing the risk of cognitive decline.

In summary, the researchers expand upon the previous literature by showing that clinical anxiety in community-dwelling individuals during the preclinical phase of AD increases the risk of incident MCI. Therefore, anxiety could be a very early marker of AD. Thus, assessing anxiety could be an important tool to identify patients at high risk of AD even before a cognitive decline occurs.

Reference:

A longitudinal investigation of Aβ, anxiety, depression, and mild cognitive impairment by Anna Pink, et al. published in the Alzheimer's Association.

https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.12504

Article Source : Alzheimer’s Association

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Shravani Dali

Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Anxiety may amplify cognitive impairment in patients with elevated amyloid beta: Study

Similar News

Does a parent's exposure to workplace chemicals affect autism in their children?

UTEP study: Drinking coffee at night increases impulsive behavior

Vitamin D in Pregnancy Linked to Child's Cognitive Development: Study Finds

Depression often associated with early menopause: Why some women are at greater risk?

Gestational Carriers at Higher Risk for Mental Illness, Emphasizing Need for Support: JAMA

Poststroke Depression Persists or Recurs in Majority of Affected Patients Over 5 Years: Study Finds

Vaginal Progesterone for Preterm Birth Prevention Not Tied to Neuropsychological Outcomes in Dichorionic Twins: Study

Study Reveals Social Factors that May Triple the Risk of Long Covid